NeoGenomics, Inc.

US$16.84As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:NEOHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR 7.63%
Div yield —
ROE (3.94%)
Diagnostics & Research
Beta (5Y) 1.83
PE TTM —
TSR TTM 72.36%
Mkt cap US$2.179B
ROIC (3.92%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$21
25.23%
(86.89%)
Hold 3|0|1|5|10
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.41
0.40
0.39
0.40
28.26%
10.87%
(0.15%)
4.48%
Revenue$M
121.0
123.8
125.1
126.4
3.29%
3.23%
(1.39%)
2.62%
Peers (US$2.179B)
Cap (US$)
PE
1.950B
15.78x
1.712B
—
Capital
TTM
5Y
10Y
Leveragex
0.591
0.584
0.489
EBIT/Intx
1.943
0.105
0.102
Own earn%
60.14
43.60
80.25
Sh yield%
41.68
49.81
49.79
Owners
Insiders/Inst%
9.42
40.14
Short interest%
3.02
SBC / revenue%
1.87
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
12
Op margin range%
16–20
$1 testx
—
Incr. ROIC%
5